Polaris Management Co. VII, L.L.C. bought CAMP

September 11, 2025 · Form 4 insider transaction

Polaris Management Co. VII, L.L.C. bought 1,221,721 shares of CAMP4 THERAPEUTICS CORPORATION at $1.53 per share, a transaction worth $1.87M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
1,221,721
Price
$1.53
Total value
$1.87M
Role10% owner
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateSeptember 11, 2025
Filing dateSeptember 11, 2025
Shares owned after2,825,500
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

On September 11, 2025, each of Polaris Partners VII, L.P. ("PP VII") and Polaris Entrepreneurs' Fund VII, L.P. ("PEF VII") acquired shares in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement, dated as of September 9, 2025, by and among the Issuer and the investors party thereto at a purchase price of $1.53 per share.; The reported securities are owned directly by PP VII. Polaris Management Co. VII, L.L.C. ("PMC VII") is the general partner of PP VII. Each of David Barrett, Brian Chee, Amir Nashat, a member of the Issuer's board of directors, and Bryce Youngren (collectively, the "PMC VII Managing Members") are the managing members of PMC VII. Each of PMC VII and the PMC VII Managing Members in their respective capacities with respect to PMC VII, may be deemed to have shared voting, investment and dispositive power with respect to the securities held by PP VII. Each of PMC VII and the PMC VII Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of the PMC VII Managing Members or PMC VII is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

View the original Form 4 on SEC EDGAR
Polaris Management Co. VII, L.L.C. bought CAMP: September 11, 2025 | Insider Trading Screener